Neurocrine Biosciences Inc - Company Profile
Powered by
All the data and insights you need on Neurocrine Biosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Neurocrine Biosciences Inc Strategy Report
- Understand Neurocrine Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Neurocrine Biosciences Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022187127A1 | Application | USE OF LUVADAXISTAT FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | A61K31/496; A61K31/50; A61K31/519; A61K31/554; A61K45/06; A61P25/18 | September 09, 2022 |
CN108473489B | Grant | VALBENAZINE盐及其多晶形物 | A61K31/4745; A61P25/00; A61P25/14; C07B2200/13; C07D471/04 | September 02, 2022 |
EP4049681A1 | Application | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ANTIPSYCHOTIKA UND VMAT2-INHIBITOR SOWIE VERWENDUNGEN DAVON | A61K2300/00; A61K31/00; A61K31/473; A61K31/4745; A61K31/519; A61K31/5415; A61K31/551; A61K31/5513; A61K45/06; A61P25/18; A61P25/24; A61P43/00 | August 31, 2022 |
AU2020207774B2 | Grant | CRF1 receptor antagonists for the treatment of congenital adrenal hyperplasia | A61K31/4245; A61K31/427; A61K31/4985; A61K31/519; A61P5/38 | August 04, 2022 |
WO2021250468A8 | Application | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | A61K2300/00; A61K31/426; A61K31/573; A61K45/06; A61K47/10; A61K47/14; A61K47/22; A61K9/0053; A61K9/0095; A61K9/107; A61K9/1635; A61K9/1652; A61K9/28; A61K9/4833; A61P5/00; C07B2200/13; C07C209/52; C07C211/29; C07C249/02; C07C251/24; C07C259/06; C07D277/42; G01N33/74 | August 04, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer